No Data
No Data
The Growth Market 250 Index continues to battle the 75-day line, with interest turning to recent IPOs.
Expectations for a fresh start: This week, the emerging markets are expected to have a solid footing, as they dealt with profit-taking sales for short-term price increases. In the prime market this week, there is an expectation of over one trillion yen in sell-offs related to the earnings of listed ETFs. Although it is considered to be factored into the market to some extent, it may be a psychological burden due to last week's significant increase. As a result, there is a possibility of cyclical searches in the emerging markets. In the first half of last week, emerging markets underwent profit-taking.
Emerging markets outlook: Will the growth market 250 index continue to battle the 75-day line and shift focus to recent IPOs?
Trading volume stagnated in the market led by large cap shareholders and the emerging market fell this week. During the same period, while the Nikkei Stock Average increased by +3.36%, the growth market index and growth market 250 index decreased by -0.56% and -0.57%, respectively, making the emerging markets dominated by the main board. Funds continued to flow toward financial stocks and precision instrument stocks in the main board market, and on July 4, the Nikkei Stock Average and TOPIX both reached the highest level in history. The market capitalization of the main board market also reached a record high of 1000 for the first time.
Cuorips: Interim report
The index ETF of Growth 250 is continuing to battle against the 75-day moving average, and biotech-related stocks remain the focus of the market.
An emerging market is likely to see profit-taking sales against the current rebound, but expect a strong outlook against the backdrop of improving investor sentiment. The Growth Market 250 Index is testing the 75-day moving average breakthrough. On June 27th, it exceeded the 75-day moving average on a closing price basis for the first time since April 1st, but over the weekend, it fell below this level. With the 25-day moving average firmly upward, this week will see a further rise to 200.
Emerging markets outlook: Growth 250 index continues to battle with its 75-day moving average, while biotech remains the focus of buying interest.
The emerging markets have been showing a clear upward trend on a monthly basis in June. In contrast with the Nikkei average's +2.56%, the growth market index rose by +3.43%, and the growth market 250 index increased by +3.65%, making it a favorable situation for emerging markets. Bio stocks were generally bought, with Sanbio <4592> rising four consecutive limits, and large-cap stocks were also strong, so the growth market index has risen for six consecutive days until June 27, and the growth market 250 index...
Stocks that moved the day before Part 2: Kura Sushi, GMO-AP, Daun, etc.
Brand name <code> 28th closing price ⇒ Previous day comparison Kura Sushi <2695> 4045-300 Negative view of the consolidated interim settlement of its subsidiary Yonago. Hino Motors <7205> 418.0-24.0 UBS Securities downgrades investment judgment. M & A Soken <9552> 4015-285 awareness of one-round feeling even with the movement of the rebound. Kose <4922> 10235-385 coverage started with a target of 10,000 yen at Jefferies Securities. Hokkaido Electric Utilities <9509> 1194-33.
No Data